首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neoplasia

缩写:NEOPLASIA

ISSN:1476-5586

e-ISSN:1476-5586

IF/分区:7.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2192
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yijia Zhang,Xinya Zhu,Liyuan Chen et al. Yijia Zhang et al.
Pancreatic ductal adenocarcinoma (PDAC) is characterized by its aggressive nature and dismal prognosis, largely attributed to its unique tumor microenvironment. However, the molecular mechanisms by which tumor-associated macrophages (TAMs) ...
Zhen Junhai,Meng Yang,Tan Zongbiao et al. Zhen Junhai et al.
Aims: Very early-onset colorectal cancer (EOCRC) was defined as CRC diagnosed before the age of 35 proposed by the latest EOCRC management guideline. Until now, the disease burden of very EOCRC has never been reported. Th...
Marta Avinent-Pérez,Frank Westermann,Samuel Navarro et al. Marta Avinent-Pérez et al.
Background: The heterogeneous prognosis in neuroblastoma, shaped by telomere maintenance mechanisms (TMMs), notably the alternative lengthening of telomeres (ALT) pathway, necessitates a refined risk classification for hi...
Shu Wang,Hong Chen,Bo Dai et al. Shu Wang et al.
Primary central nervous system diffused large B-cell lymphoma (PCNS-DLBCL) is a rare type of non-Hodgkin lymphoma restricted to the central nervous system (CNS). To explore its specific pathogenesis and therapeutic targets, we performed mul...
Zhigang Huang,Bin Liu,Xiaoju Li et al. Zhigang Huang et al.
Bladder cancer is a prevalent malignancy within the urinary system. Prior research has suggested that glutamine metabolism plays a crucial role in driving bladder cancer progression. However, the precise molecular mechanism governing glutam...
Annat Raiter,Yael Barhum,Julia Lipovetsky et al. Annat Raiter et al.
Triple-negative breast cancer (TNBC) is an aggressive subtype that accounts for 10-15 % of breast cancer. Current treatment of high-risk early-stage TNBC includes neoadjuvant chemo-immune therapy. However, the substantial variation in immun...
Soon Sang Park,Tae Hoon Roh,Yoshiaki Tanaka et al. Soon Sang Park et al.
Glioblastoma, isocitrate dehydrogenase (IDH)-wildtype (GBM), is the most malignant brain tumor in adults, with limited therapeutic intervention. Previous studies have identified a few prognostic markers for GBM, including the methylation st...
Xumin Zhou,Shilong Cheng,Zhongjie Chen et al. Xumin Zhou et al.
Immunotherapy with checkpoint inhibitors produced significant clinical responses in a subset of cancer patients who were resistant to prior therapies. However, Castration-resistant prostate cancer (CRPC) is seriously lack of T cell infiltra...